Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 233, doi. 10.1007/s00262-007-0370-8
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 2
Results: 14
1
2
Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 247, doi. 10.1007/s00262-007-0371-7
- By:
- Publication type:
- Article
3
Tumor stromal barriers to the success of adoptive T cell therapy.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
4
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 185, doi. 10.1007/s00262-007-0361-9
- By:
- Publication type:
- Article
5
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 175, doi. 10.1007/s00262-007-0360-x
- By:
- Publication type:
- Article
6
CRMP5 antibodies in patients with small-cell lung cancer or thymoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 227, doi. 10.1007/s00262-007-0369-1
- By:
- Publication type:
- Article
7
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 271, doi. 10.1007/s00262-007-0355-7
- By:
- Publication type:
- Article
8
A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 155, doi. 10.1007/s00262-007-0357-5
- By:
- Publication type:
- Article
9
New T cell epitopes identified from an anti-idiotypic antibody mimicking ovarian cancer associated antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 143, doi. 10.1007/s00262-007-0354-8
- By:
- Publication type:
- Article
10
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 197, doi. 10.1007/s00262-007-0362-8
- By:
- Publication type:
- Article
11
Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8<sup>+</sup> cytotoxic T lymphocytes and natural killer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 165, doi. 10.1007/s00262-007-0359-3
- By:
- Publication type:
- Article
12
MAGE-A3<sub>161–175 </sub>contains an HLA-DRβ4 restricted natural epitope poorly formed through indirect presentation by dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 207, doi. 10.1007/s00262-007-0364-6
- By:
- Publication type:
- Article
13
Expression of a dendritic cell maturation marker CD83 on tumor cells from lung cancer patients and several human tumor cell lines: is there a biological meaning behind it?
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 265, doi. 10.1007/s00262-007-0344-x
- By:
- Publication type:
- Article
14
Control of lymphocyte infiltration of lung tumors in mice by host’s genes: mapping of four Lynf (lymphocyte infiltration) loci.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 217, doi. 10.1007/s00262-007-0367-3
- By:
- Publication type:
- Article